McKessonFRA:MCK +1.25%86 ROA % is 8.13% as of Mar. 2026, which is 156% above its 10-year median of 3.18. GuruFocus rates FRA:MCK with a GF Score™ of 86/100 and a GF Value™ of €707.29 (Fairly Valued). The stock has 2 warning signs investors should review. Among 120 Medical Distribution companies, McKesson ranks better than 80% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. McKesson's annualizedNet Income for the quarter that ended in Mar. 2026 was €5,820 Mil.
McKesson's average Total Assets over the quarter that ended in Mar. 2026 was €71,554 Mil. Therefore, McKesson's annualized ROA % for the quarter that ended in Mar. 2026 was 8.13%.
The historical rank and industry rank for McKesson's ROA % or its related term are showing as below:
FRA:MCK'
s ROA % Range Over the Past 10 Years
Min: -7.19 Med: 3.18 Max: 8.63
Current: 5.85
During the past 13 years, McKesson's highest ROA % was 8.63%. The lowest was -7.19%. And the median was 3.18%.
FRA:MCK's ROA % is ranked better than 80% of 120
companies
in the Medical Distribution industry
Industry Median: 2.23
vs FRA:MCK: 5.85
McKesson (FRA:MCK) ROA % Explanation
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is four times the quarterly (Mar. 2026) net income data. The Revenue data used here is four times the quarterly (Mar. 2026) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
McKesson ROA % Related Terms
McKesson ROA % Historical Data
* Premium members only.
The historical data trend for McKesson's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Distribution subindustry, McKesson's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
McKesson ROA % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, McKesson's ROA % distribution charts can be found below:
* The bar in red indicates where McKesson's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
ROA % is displayed in the 30-year financial page.
McKesson (FRA:MCK) has a ROA % of 8.13% as of Mar. 2026. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on McKesson and its competitors. This is 156% above median its historical median of 3.18. According to the industry distribution chart, McKesson ranks #24 out of 120 companies in the Medical Distribution industry, placing it in the top 20%.
Is McKesson's ROA % too high?
McKesson's current ROA % of 8.13% is 156% above median its 10-year median of 3.18. The Medical Distribution industry median ROA % is 2.23. McKesson's value of 8.13% is 264.6% above this industry median. Based on the distribution chart, McKesson ranks #24 out of 120 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, McKesson has a GF Score™ of 86/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does McKesson's ROA % compare to COR and CAH?
According to the Medical Distribution industry distribution chart, McKesson ranks #24 out of 120 companies for ROA %. This places McKesson in the top 20% of its industry — outperforming the majority of peers. The industry median ROA % is 2.23. McKesson's value of 8.13% is 264.6% above this benchmark. While the company's 10-year median is 3.18 vs. the industry median of 2.23, McKesson has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Medical Distribution company?
The median ROA % among Medical Distribution companies is 2.23, based on 120 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. McKesson's current ROA % of 8.13% is 264.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on McKesson and its competitors. For the Medical Distribution industry, the median ROA % is 2.23 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. McKesson's current ROA % is 8.13%, which is 156% above median its own 10-year median of 3.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is McKesson stock overvalued right now?
Based on GuruFocus' analysis, McKesson (FRA:MCK) is currently considered Fairly Valued. The stock's GF Value™ is €707.29, compared to a current price of €682.80 — trading 3.5% below its estimated fair value. The current ROA % is 8.13%, which is 156% above median its 10-year median of 3.18 and 264.6% above the Medical Distribution industry median of 2.23. McKesson's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For McKesson (FRA:MCK), the current ROA % is 8.13% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is McKesson (FRA:MCK) Overvalued in 2026?
Based on GuruFocus' analysis, McKesson stock appears to be undervalued.
The current stock price of €682.80 is trading 3.5% below its estimated GF Value™ of €707.29.
GuruFocus considers McKesson to be Fairly Valued.
Key valuation signals for FRA:MCK:
ROA %: 8.13% (156% above median its 10-year median of 3.18)
GF Value™: €707.29 vs. price of €682.80 (3.5% below fair value)
Industry Position: 264.6% above the Medical Distribution median (#24 of 120)
No single metric tells the full story. See the FRA:MCK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
McKesson is one of three leading pharmaceutical wholesalers in the US engaged in sourcing and distributing branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with Cencora and Cardinal Health, the three account for over 90% of the US pharmaceutical wholesale industry. Outside the US market, McKesson engages in pharmaceutical wholesale and distribution in Canada. Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
86GF Score
Get the complete analysis for FRA:MCK
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:MCK has been successfully added to your 
